DDD Partners’s ResMed RMD Stock Holding History

DDD Partners’s Portfolio RMD Stock Details RMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$241K	Buy	1,089 +8	+0.7%	+$1.74K	0.01%	150
2026 Q2	$211K	Buy	1,081 +20	+2%	+$4.14K	0.01%	155
2026 Q1	$238K	Sell	1,061 -4	-0.4%	-$997	0.02%	125
2025 Q4	$257K	Buy	1,065 +2	+0.2%	+$511	0.02%	114
2025 Q3	$291K	Hold	1,063	–	–	0.02%	105
2025 Q2	$274K	Buy	1,063 +2	+0.2%	+$477	0.03%	100
2025 Q1	$238K	Sell	1,061 -2	-0.2%	-$467	0.03%	93
2024 Q4	$243K	Buy	1,063 +2	+0.2%	+$482	0.03%	89
2024 Q3	$259K	Hold	1,061	–	–	0.03%	92
2024 Q2	$203K	Hold	1,061	–	–	0.02%	92
2024 Q1	$210K	Buy	+1,061	New	+$194K	0.03%	86
2023 Q3	–	Sell	-1,165	Closed	-$255K	–	93
2023 Q2	$255K	Hold	1,165	–	–	0.04%	83
2023 Q1	$255K	Hold	1,165	–	–	0.04%	71
2022 Q4	$242K	Hold	1,165	–	–	0.04%	69
2022 Q3	$254K	Hold	1,165	–	–	0.05%	75
2022 Q2	$244K	Hold	1,165	–	–	0.04%	75
2022 Q1	$283K	Hold	1,165	–	–	0.04%	71
2021 Q4	$303K	Buy	+1,165	New	+$302K	0.04%	77

Other funds holding RMD

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Citigroup New York $308B AUM 40.94% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return

Welch & Forbes Boston, Massachusetts $8.34B AUM 13.98% 1-Year Est. Return

Tandem Investment Advisors Charleston, South Carolina $1.39B AUM 7.74% 1-Year Est. Return

DDD Partners's RMD Position: Q3 2026 in Review

DDD Partners increased its ResMed (RMD) stake by 0.74% in Q3 2026, buying an estimated $1.74K and bringing the position to 1,089 shares worth $241K. The position accounts for 0.01% of the portfolio, ranked #150.

DDD Partners first reported a position in RMD in Q4 2021 and has held it in 18 quarters since. The position peaked at $303K in Q4 2021. 424 funds tracked by Wall St. Rank hold RMD as of Q3 2026.

DDD Partners held 1,089 shares of ResMed worth $241K as of Q3 2026.
DDD Partners bought 8 ResMed shares in Q3 2026, an estimated $1.74K.
ResMed made up 0.01% of DDD Partners's portfolio in Q3 2026, its #150 holding.
DDD Partners first reported a position in ResMed in Q4 2021 and has held it in 18 quarters since.
DDD Partners's ResMed position peaked at $303K in Q4 2021.
424 funds tracked by Wall St. Rank held ResMed as of Q3 2026.

Based on DDD Partners's 13F filing for Q3 2026, filed 2 Nov 2026.